On December 6, 2018, Fred Oeschger resigned as a member of the board of directors of GeneThera, Inc. In his resignation letter, Mr. Oeschger stated that he did not feel that Company information was communicated as timely or as completely as necessary for him to fulfill his obligations as a board member. He also stated that he disagreed with the Company’s decision to make filings and other public communications without board approval.